Advertisement
Screener

GLAUKOS Corp (GKOS) Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised

GLAUKOS Corp Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised

GLAUKOS Corp (GKOS) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $2.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2026-07-29

  • GLAUKOS Corp proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2026-06-30 was $0.00.
  • GLAUKOS Corp proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2026-03-31 was $2.38M, a 19.59% decline year-over-year.
  • GLAUKOS Corp proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-12-31 was $0.00.
  • GLAUKOS Corp proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-09-30 was $4.72M, a 0.08% decline year-over-year.
  • GLAUKOS Corp proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2025 was $7.69M, a 3.64% increase from fiscal 2024.
  • GLAUKOS Corp proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2024 was $7.42M, a 18.13% increase from fiscal 2023.
  • GLAUKOS Corp proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2023 was $6.28M, a 11.51% increase from fiscal 2022.
  • GLAUKOS Corp proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2022 was $5.63M, a 16.88% increase from fiscal 2021.
Period endProceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 3 monthProceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 monthProceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 9 monthProceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$2.38M
10-Q · filed 2026-07-29
$2.38M
derived: sum of 3 quarters · filed 2026-07-29
$7.11M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31$2.38M
10-Q · filed 2026-04-30
$2.38M
derived: sum of 2 quarters · filed 2026-04-30
$7.11M
derived: sum of 3 quarters · filed 2026-04-30
$7.11M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23
$4.72M
derived: sum of 2 quarters · filed 2026-02-23
$4.72M
derived: sum of 3 quarters · filed 2026-07-29
$7.69M
10-K · filed 2026-02-23
2025-09-30$4.72M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31
$4.72M
derived: sum of 2 quarters · filed 2026-07-29
$7.69M
10-Q · filed 2025-10-31
$7.69M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
$2.96M
10-Q · filed 2026-07-29
$2.96M
derived: sum of 3 quarters · filed 2026-07-29
$7.69M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31$2.96M
10-Q · filed 2026-04-30
$2.96M
derived: sum of 2 quarters · filed 2026-04-30
$7.69M
derived: sum of 3 quarters · filed 2026-04-30
$7.69M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23
$4.73M
derived: sum of 2 quarters · filed 2026-02-23
$4.73M
derived: sum of 3 quarters · filed 2026-02-23
$7.42M
10-K · filed 2026-02-23
2024-09-30$4.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31
$4.73M
derived: sum of 2 quarters · filed 2025-10-31
$7.42M
10-Q · filed 2025-10-31
$7.42M
derived: sum of 4 quarters · filed 2026-02-23
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04
$2.69M
10-Q · filed 2025-08-04
$2.69M
derived: sum of 3 quarters · filed 2026-02-23
$6.80M
derived: sum of 4 quarters · filed 2026-02-23
2024-03-31$2.69M
10-Q · filed 2025-05-01
$2.69M
derived: sum of 2 quarters · filed 2026-02-23
$6.80M
derived: sum of 3 quarters · filed 2026-02-23
$6.80M
derived: sum of 4 quarters · filed 2026-02-23
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23
$4.12M
derived: sum of 2 quarters · filed 2026-02-23
$4.12M
derived: sum of 3 quarters · filed 2026-02-23
$6.28M
10-K · filed 2026-02-23
2023-09-30$4.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
$4.12M
derived: sum of 2 quarters · filed 2024-11-05
$6.28M
10-Q · filed 2024-11-05
$6.28M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
$2.16M
10-Q · filed 2024-08-02
$2.16M
derived: sum of 3 quarters · filed 2025-02-25
$6.01M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31$2.16M
10-Q · filed 2024-05-03
$2.16M
derived: sum of 2 quarters · filed 2025-02-25
$6.01M
derived: sum of 3 quarters · filed 2025-02-25
$6.01M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$3.85M
derived: sum of 2 quarters · filed 2025-02-25
$3.85M
derived: sum of 3 quarters · filed 2025-02-25
$5.63M
10-K · filed 2025-02-25
2022-09-30$3.85M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01
$3.85M
derived: sum of 2 quarters · filed 2023-11-01
$5.63M
10-Q · filed 2023-11-01
$5.63M
derived: sum of 4 quarters · filed 2024-02-23
2022-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
$1.78M
10-Q · filed 2023-08-02
$1.78M
derived: sum of 3 quarters · filed 2024-02-23
$5.05M
derived: sum of 4 quarters · filed 2024-02-23
2022-03-31$1.78M
10-Q · filed 2023-05-04
$1.78M
derived: sum of 2 quarters · filed 2024-02-23
$5.05M
derived: sum of 3 quarters · filed 2024-02-23
$5.05M
derived: sum of 4 quarters · filed 2024-02-23
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
$3.27M
derived: sum of 2 quarters · filed 2024-02-23
$3.27M
derived: sum of 3 quarters · filed 2024-02-23
$4.82M
10-K · filed 2024-02-23
2021-09-30$3.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
$3.27M
derived: sum of 2 quarters · filed 2022-11-04
$4.82M
10-Q · filed 2022-11-04
$4.82M
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
$1.55M
10-Q · filed 2022-08-05
$1.55M
derived: sum of 3 quarters · filed 2023-02-24
$4.30M
derived: sum of 4 quarters · filed 2023-02-24
2021-03-31$1.55M
10-Q · filed 2022-05-05
$1.55M
derived: sum of 2 quarters · filed 2023-02-24
$4.30M
derived: sum of 3 quarters · filed 2023-02-24
$4.30M
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$2.75M
derived: sum of 2 quarters · filed 2023-02-24
$2.75M
derived: sum of 3 quarters · filed 2023-02-24
$4.03M
10-K · filed 2023-02-24
2020-09-30$2.75M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08
$2.75M
derived: sum of 2 quarters · filed 2021-11-08
$4.03M
10-Q · filed 2021-11-08
$4.03M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$1.28M
10-Q · filed 2021-08-05
$1.28M
derived: sum of 3 quarters · filed 2022-02-28
$3.76M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31$1.28M
10-Q · filed 2021-05-06
$1.28M
derived: sum of 2 quarters · filed 2022-02-28
$3.76M
derived: sum of 3 quarters · filed 2022-02-28
$3.76M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$2.49M
derived: sum of 2 quarters · filed 2022-02-28
$2.49M
derived: sum of 3 quarters · filed 2022-02-28
$3.39M
10-K · filed 2022-02-28
2019-09-30$2.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$2.49M
derived: sum of 2 quarters · filed 2020-11-05
$3.39M
10-Q · filed 2020-11-05
$3.39M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$902.00K
10-Q · filed 2020-08-07
$902.00K
derived: sum of 3 quarters · filed 2021-03-01
$3.02M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$902.00K
10-Q · filed 2020-05-07
$902.00K
derived: sum of 2 quarters · filed 2021-03-01
$3.02M
derived: sum of 3 quarters · filed 2021-03-01
$3.02M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$2.12M
derived: sum of 2 quarters · filed 2021-03-01
$2.12M
derived: sum of 3 quarters · filed 2021-03-01
$3.51M
10-K · filed 2021-03-01
2018-09-30$2.12M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$2.12M
derived: sum of 2 quarters · filed 2019-11-06
$3.51M
10-Q · filed 2019-11-06
$3.51M
derived: sum of 4 quarters · filed 2020-03-02
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$1.39M
10-Q · filed 2019-08-08
$1.39M
derived: sum of 3 quarters · filed 2020-03-02
$1.39M
derived: sum of 4 quarters · filed 2020-03-02
2018-03-31$1.39M
10-Q · filed 2019-05-08
$1.39M
derived: sum of 2 quarters · filed 2020-03-02
$1.39M
derived: sum of 3 quarters · filed 2020-03-02
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02
$0.00
derived: sum of 2 quarters · filed 2020-03-02
$968.00K
10-K · filed 2020-03-02
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
$968.00K
10-Q · filed 2018-11-07
2017-06-30$968.00K
10-Q · filed 2018-08-06
2016-12-31$1.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$1.15M
derived: sum of 2 quarters · filed 2019-02-28
$1.95M
10-K · filed 2019-02-28
2016-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08
$793.00K
10-Q · filed 2017-11-08
2016-06-30$793.00K
10-Q · filed 2017-08-07
2015-12-31$1.16M
10-K · filed 2018-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSULET CORP (PODD)United States$9.420B28.12
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
Penumbra Inc (PEN)United States$12.596B77.33
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44
TELEFLEX INC (TFX)United States$5.093B-5.44
HAEMONETICS CORP (HAE)United States$4.821B36.52
Heartflow, Inc. (HTFL)United States$4.225B
ICU MEDICAL INC/DE (ICUI)United States$4.153B18.85